# Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer

> **NCT03459729** · EARLY_PHASE1 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 6 (actual)

## Conditions studied

- Squamous Cell Carcinoma of the Oral Cavity

## Interventions

- **DRUG:** Antitumor B

## Key facts

- **NCT ID:** NCT03459729
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-24
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-02-16
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-01-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03459729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03459729, "Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03459729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*